Florida bill advances

Article

 

Tallahassee, FL-At press time, Florida optometrists were awaiting a vote in the Florida Senate appropriations committee on SB278, a bill which would grant additional prescribing authority to optometrists. Previously, the Florida Senate voted 10-0 to approve SB278.

“Originally it was to be voted on by the full Senate as a special calendar item, but it was decided to go the regular, full-three-reading route,” says Kimberly Reed, OD, FAAO, associate professor at Nova Southeastern University College of Optometry. Dr. Reed provided testimony during hearings for SB278.

The bill would grant optometrists the ability to prescribe oral medication, in the language of SB278: “requiring a certified optometrist to complete a course and examination on general and ocular pharmaceutical agents before administering or prescribing oral ocular pharmaceutical agents.”

A similar bill, HB239, recently passed the Florida House 116-0. “I am very pleased that we seem to have come to an agreement on this bill. It was the direct result of many discussions by interested individuals working on behalf of the patients in the state of Florida,” says Dr. Reed.ODT

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
© 2025 MJH Life Sciences

All rights reserved.